Pharmacological Management of Manic Episodes
Publisher
Springer Healthcare Ltd.
Reference129 articles.
1. Yatham LN, Kennedy SH, O’Donovan C; Canadian Network for Mood and Anxiety Treatments. Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies. Bipolar Disord. 2005;7(suppl 3):5-69.
2. Fountoulakis KN, Vieta E, Sanchez-Moreno J, et al. Treatment guidelines for bipolar disorder: a critical review. J Affect Disord. 2005;86:1-10.
3. Yatham LN, Kennedy SH, Schaffer A, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. Bipolar Disord 2009; 11:225-255.
4. Goodwin GM; Consensus Group of the British Association for Psychopharmacology. Evidence based guidelines for treating bipolar disorder: revised second edition— recommendations from the British Association for Psychopharmacology. J Psychopharmacol. 2009;23:346-388.
5. Grunze H, Vieta E, Goodwin GM, et al. WFSBP Task Force on Treatment Guidelines for Bipolar Disorders. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders.: update 2009 on the treatment of acute mania. World J Biol Psychiatry. 2009;10:85-116.